Interleukin-8 gene silencing on pancreatic cancer cells using biodegradable polymer nanoplexes.

作者: Guimiao Lin , Chengbin Yang , Rui Hu , Chih-Kuang Chen , Wing-Cheung Law

DOI: 10.1039/C3BM60325C

关键词: Tertiary amineGene silencingTransfectionBiologySmall interfering RNACancer researchMolecular biologyGenetic enhancementRNA interferencePancreatic cancerGene expression

摘要: Pancreatic cancer is one of the deadliest cancers throughout world with rarely efficient therapies currently available. Gene therapy on pancreatic through small interfering RNA (siRNA)-based interference (RNAi) has shown great potential and attracted much attention. However, due to fragile nature nucleic acid, application RNAi as a safe carrier faces challenges. In this contribution, self-assembly regime, which based well-defined cationic polylactides (CPLAs) tertiary amine groups, been used encapsulate protect siRNAs from fast degradation. CPLA degradable formulation that allowed us deliver targeting proangiogenic chemokine interleukin-8 (IL-8) cells for gene therapy. Stable IL-8 siRNA–CPLA nanoplexes were successfully formed by electrostatic force high transfection efficiencies two cell lines. We did not observe any cytotoxicity these CPLAs over large concentration range via viability evaluations. More importantly, silencing expression significantly attenuated proliferation cells. Our preliminary results support future development might provide an effective treatment approach towards cancer.

参考文章(38)
L. Xu, I.J. Fidler, Interleukin 8: an autocrine growth factor for human ovarian cancer. Oncology Research. ,vol. 12, pp. 97- 106 ,(2001) , 10.3727/096504001108747567
Sara Torgerson, Lauren A Wiebe, Supportive Care of the Patient With Advanced Pancreatic Cancer Oncology. ,vol. 27, pp. 183- 190 ,(2013)
Fischer, L. Tan, Application of RNAi to cancer research and therapy Frontiers in Bioscience. ,vol. 10, pp. 1946- ,(2005) , 10.2741/1670
Wei Lv, RNAi technology: A Revolutionary tool for the colorectal cancer therapeutics World Journal of Gastroenterology. ,vol. 12, pp. 4636- 4639 ,(2006) , 10.3748/WJG.V12.I29.4636
Sally Lehrman, Virus treatment questioned after gene therapy death Nature. ,vol. 401, pp. 517- 518 ,(1999) , 10.1038/43977
Kathryn A. Whitehead, Robert Langer, Daniel G. Anderson, Knocking down barriers: advances in siRNA delivery Nature Reviews Drug Discovery. ,vol. 8, pp. 129- 138 ,(2009) , 10.1038/NRD2742
Antonio Strillacci, Cristiana Griffoni, Maria Chiara Valerii, Giorgia Lazzarini, Vittorio Tomasi, Enzo Spisni, RNAi-based strategies for cyclooxygenase-2 inhibition in cancer. BioMed Research International. ,vol. 2010, pp. 828045- 828045 ,(2010) , 10.1155/2010/828045
A. Browne, R. Sriraksa, T. Guney, N. Rama, S. Van Noorden, E. Curry, H. Gabra, E. Stronach, M. El-Bahrawy, Differential expression of IL-8 and IL-8 receptors in benign, borderline and malignant ovarian epithelial tumours. Cytokine. ,vol. 64, pp. 413- 421 ,(2013) , 10.1016/J.CYTO.2013.05.006
Andrew Scott Paulson, Hop S. Tran Cao, Margaret A. Tempero, Andrew M. Lowy, Therapeutic advances in pancreatic cancer. Gastroenterology. ,vol. 144, pp. 1316- 1326 ,(2013) , 10.1053/J.GASTRO.2013.01.078
Jacques Ferlay, Hai-Rim Shin, Freddie Bray, David Forman, Colin Mathers, Donald Maxwell Parkin, Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. International Journal of Cancer. ,vol. 127, pp. 2893- 2917 ,(2010) , 10.1002/IJC.25516